◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

RECURSION PHARMACEUTICALS, INC.

CIK: 1601830 SIC: 2836
$74.68M
Revenue
$-644.76M
Net Income
4.99%
Gross Margin
-867.87%
Op. Margin
$-725.42M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 7 of 15 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
+ Total Revenue $35.54M $5.17M $19.22M $14.74M $4.55M $26.08M $14.42M
Revenue Growth % (YoY) 681.7% -80.2% 33.3% nan% nan% nan% nan%
Cost of Revenue $14.28M $14.69M $20.16M $21.83M $12.79M $12.08M $9.20M
+ Gross Profit $21.26M $-9.51M $-938.00K $-7.08M $-8.25M $14.00M $5.22M
Gross Margin % 59.8% -183.8% -4.9% -48.0% -181.4% 53.7% 36.2%
Operating Expenses $143.87M $177.38M $195.45M $206.11M $188.31M $124.44M $114.96M
Research & Development $95.94M $121.06M $128.64M $129.63M $98.33M $74.60M $73.93M
+ Operating Income $-108.33M $-172.20M $-176.23M $-191.37M $-183.77M $-98.35M $-100.54M
Operating Margin % -304.8% -3327.6% -916.8% -1297.9% -4042.4% -377.1% -697.4%
Other Income/Expense $232.00K $9.95M $4.33M $-11.28M $4.87M $2.68M $2.48M
Income Before Tax $-108.10M $-162.25M $-171.90M $-202.65M $-178.90M $-95.67M $-98.06M
Income Tax Expense $20.00K $3.00K - $-158.00K $7.00K $167.00K $-523.00K
+ Net Income $-108.12M $-162.25M $-171.90M $-202.49M $-178.91M $-95.84M $-97.54M
Net Margin % -304.2% -3135.3% -894.2% -1373.3% -3935.5% -367.5% -676.6%
Basic EPS -0.17 -0.36 -0.41 -0.50 -0.57 -0.34 -0.40
Diluted EPS -0.17 -0.36 -0.41 -0.50 -0.57 -0.34 -0.40
Basic Shares Outstanding - 447.0M 417.4M 402.8M 20.8M 282.6M 242.2M
Diluted Shares Outstanding - 447.0M 417.4M 402.8M 20.8M 282.6M 242.2M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Cash & Cash Equivalents $743.29M $659.84M $525.11M $500.45M $594.35M $427.65M $474.34M
Other Current Assets $28.57M $29.22M $37.34M $32.02M $67.71M $42.72M $43.73M
Total Current Assets $812.85M $714.11M $587.16M $584.14M $714.27M $474.17M $522.38M
Property Plant & Equipment $103.93M $111.71M $120.04M $126.83M $141.06M $84.41M $83.63M
Goodwill $162.16M $162.04M $164.27M $158.11M $148.87M $52.06M $52.06M
Intangible Assets $309.90M $322.34M $341.32M $335.79M $335.86M $34.09M $38.21M
Other Non-current Assets $12.75M $14.66M $9.42M $14.78M $8.82M $360.00K $308.00K
Total Assets $1.47B $1.40B $1.30B $1.31B $1.45B $726.50M $775.86M
Accounts Payable $18.12M $13.94M $19.31M $25.09M $21.61M $2.26M $3.76M
Accrued Liabilities $70.23M $53.10M $64.28M $56.80M $81.87M $40.60M $33.40M
Deferred Revenue $37.60M $47.36M $39.69M $39.65M $61.77M $49.58M $32.20M
Total Current Liabilities $147.71M $155.10M $164.03M $141.98M $187.47M $108.89M $86.08M
Long-term Debt $9.56M $11.90M $14.20M $16.45M $19.02M $20.51M $22.92M
Deferred Tax Liabilities $23.25M $23.31M $23.78M $22.44M $16.57M $168.00K -
Other Non-current Liabilities $2.08M $1.03M $1.56M $4.79M $4.73M $3.00M $3.00M
Total Liabilities $343.26M $352.58M $383.21M $371.29M $413.82M $201.94M $191.41M
Common Stock $5.00K $5.00K $4.00K $4.00K $4.00K $3.00K $3.00K
Retained Earnings $-2.08B $-1.97B $-1.81B $-1.63B $-1.43B $-1.25B $-1.16B
Total Stockholders Equity $1.13B $1.05B $919.15M $933.95M $1.03B $524.56M $584.45M
Total Liabilities & Equity $1.47B $1.40B $1.30B $1.31B $1.45B $726.50M $775.86M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Net Income $-108.12M $-162.25M $-374.38M $-202.49M $-178.91M $-284.75M $-97.54M
Depreciation & Amortization $19.48M $64.22M $43.18M $19.33M $12.95M $23.54M $16.34M
Stock-based Compensation $23.76M $87.46M $62.22M $36.06M $30.78M $50.90M $32.65M
Change in Payables $4.42M $-7.04M $-1.15M $3.69M $8.12M $-1.69M $-174.00K
Operating Cash Flow $-46.07M $-325.74M $-208.38M $-131.96M $-115.43M $-243.74M $-184.52M
Capital Expenditure $1.24M $5.22M $4.98M $1.83M $1.30M $12.40M $7.83M
Acquisitions - - - - $-277.10M - -
Purchases of Investments - $3.81M $1.50M $1.00M - - -
Investing Cash Flow $-1.24M $-15.63M $-13.08M $-7.27M $275.46M $-15.40M $-10.84M
Debt Repayment - - - - - - $52.00K
Stock Issued $133.38M $395.48M $141.02M $41.02M $11.03M $289.39M $272.42M
Financing Cash Flow $132.01M $389.53M $138.19M $40.53M $10.64M $293.48M $277.02M
Net Change in Cash $86.78M $64.12M $-69.18M $-93.87M $167.19M $34.41M $81.33M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $5.17M $26.08M $39.14M $54.29M
Cost of Revenue $14.69M $12.08M $56.68M $32.44M
Operating Expenses $177.38M $124.44M $578.94M $349.53M
Research & Development $121.06M $74.60M $379.33M $216.09M
Operating Income $-172.20M $-98.35M $-539.80M $-295.24M
Other Income/Expense $9.95M $2.68M $3.00M $9.35M
Income Before Tax $-162.25M $-95.67M $-536.79M $-285.89M
Income Tax Expense $3.00K $167.00K $-156.00K $-1.13M
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Basic EPS -0.36 -0.34 -1.27 -1.12
Diluted EPS -0.36 -0.34 -1.27 -1.12
Basic Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Diluted Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $659.84M $594.35M
Other Current Assets $29.22M $38.11M
Total Current Assets $714.11M $714.27M
Property Plant & Equipment $111.71M $141.06M
Goodwill $162.04M $148.87M
Intangible Assets $322.34M $335.86M
Other Non-current Assets $14.66M $8.82M
Total Assets $1.40B $1.45B
Accounts Payable $13.94M $21.61M
Accrued Liabilities $53.10M $81.87M
Deferred Revenue $47.36M $61.77M
Total Current Liabilities $155.10M $187.47M
Long-term Debt $11.90M $19.02M
Deferred Tax Liabilities $23.31M $16.57M
Other Non-current Liabilities $1.03M $4.73M
Total Liabilities $352.58M $413.82M
Common Stock $5.00K $4.00K
Retained Earnings $-1.97B $-1.43B
Total Stockholders Equity $1.05B $1.03B
Total Liabilities & Equity $1.40B $1.45B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Depreciation & Amortization - - $64.22M $23.54M
Stock-based Compensation - - $87.46M $50.90M
Change in Payables - - $-7.04M $-1.69M
Operating Cash Flow - - $-325.74M $-243.74M
Capital Expenditure - - $5.22M $12.40M
Purchases of Investments - - $3.81M -
Investing Cash Flow - - $-15.63M $-15.40M
Stock Issued - - $395.48M $289.39M
Financing Cash Flow - - $389.53M $293.48M
Net Change in Cash - - $64.12M $34.41M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...